Request for Covid-19 Impact Assessment of this Report

Take Action
Healthcare

Global Prenatal and New-born Genetic Testing Market Size study, by Technology (Screening and Diagnostic), by Diseases (Downs Syndrome, Phenylketonuria, Cystic Fibrosis, Sickle cell Anemia and Others), by End-Use (Hospitals, Maternity and Specialty Clinics and Diagnostic centers) and Regional Forecasts 2020-2026

  • BIZ3837193
  • 200 Pages
  • April 2020
  • Healthcare
Download Sample    Get Discount   
 
Global Prenatal and New-born Genetic Testing Market is valued approximately USD 13.98 Billion in 2019 and is anticipated to grow with a healthy growth rate of more than 11.9% over the forecast period 2019-2026. Prenatal and New-Born testing is an advanced technology used for genetic screening in the healthcare industry to identify the genetic or other birth defects in newborn baby at early stage. The test is conducted during time interval of pregnancy to determine the health of the fetus at an early stage and helps in identifying various genetic and chromosomal anomalies such as birth defects, gene mutations and cystic fibrosis etc. Therefore, such advent features of prenatal and new-born genetic testing helps parents to detect early abnormal diseases in fetus to take suitable treatment. Hence, rapid growth in birth of abnormal kids along with rising cases of new-born babies with genetic disorder is expected to drive the growth of market over the forecast years. For instance: as per the World Health Organization, over an estimate 303000 newborns die within 4 weeks of birth every year globally due to the congenital anomalies. Also, as per the Centers of Diseases Control, birth defects affect one in every 33 babies (about 3% of all babies) born in the United States each year and is a leading cause of infant deaths, accounting for 20% of all infant deaths. Thus, increase in cases of birth defects in newborn baby and remarkable application of Prenatal and New-born Genetic Testing to identify it at an early stage are the factors accelerating the growth of market over the forecast years. However, lack of advanced infrastructure and skilled labor in developing region are the factors that hamper the growth of market.

The regional analysis of global Prenatal and New-born Genetic Testing market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Asia Pacific is the leading/significant region across the world in terms of market share owing to the due to the rapid growth in birth of abnormal kids along with rising cases of new-born babies with genetic disorder in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026. Factors such as advancement in genetic screening technologies in the region would create lucrative growth prospects for the Prenatal and New-born Genetic Testing market across Asia-Pacific region.

Major market player included in this report are:

Abbott Laboratories

Agilent

AutoGenomics

Ariosa Diagnostics

Baebies

Berry Genomics Co. Ltd

BGI

Biocartis Group NV

Natera Inc.

Sequenom Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Diseases offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Technology:

Screening

Diagnostic

By Diseases:

Downs Syndrome

Phenylketonuria

Cystic Fibrosis

Sickle cell Anaemia

Others

By End-Use:

Hospitals

Maternity and Specialty Clinics

Diagnostic centers

By Region:

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017, 2018

Base year – 2019

Forecast period – 2020 to 2026

Target Audience of the Global Prenatal and New-born Genetic Testing Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)

1.2.1. Prenatal and New-born Genetic Testing Market, by Region, 2018-2026 (USD Billion)

1.2.2. Prenatal and New-born Genetic Testing Market, by Technology, 2018-2026 (USD Billion)

1.2.3. Prenatal and New-born Genetic Testing Market, by Disease, 2018-2026 (USD Billion)

1.2.4. Prenatal and New-born Genetic Testing Market, by End-Use, 2018-2026 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Prenatal and New-born Genetic Testing Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Prenatal and New-born Genetic Testing Market Dynamics

3.1. Prenatal and New-born Genetic Testing Market Impact Analysis (2018-2026)

3.1.1. Market Drivers

3.1.2. Market Challenges

3.1.3. Market Opportunities

Chapter 4. Global Prenatal and New-born Genetic Testing Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Prenatal and New-born Genetic Testing Market, by Technology

5.1. Market Snapshot

5.2. Global Prenatal and New-born Genetic Testing Market by Technology, Performance - Potential Analysis

5.3. Global Prenatal and New-born Genetic Testing Market Estimates & Forecasts by Technology 2016-2026 (USD Billion)

5.4. Prenatal and New-born Genetic Testing Market, Sub Segment Analysis

5.4.1. Screening

5.4.2. Diagnostic

Chapter 6. Global Prenatal and New-born Genetic Testing Market, by Disease

6.1. Market Snapshot

6.2. Global Prenatal and New-born Genetic Testing Market by Disease, Performance - Potential Analysis

6.3. Global Prenatal and New-born Genetic Testing Market Estimates & Forecasts by Disease 2016-2026 (USD Billion)

6.4. Prenatal and New-born Genetic Testing Market, Sub Segment Analysis

6.4.1. Downs Syndrome

6.4.2. Phenylketonuria

6.4.3. Cystic Fibrosis

6.4.4. Sickle cell Anaemia

6.4.5. Others

Chapter 7. Global Prenatal and New-born Genetic Testing Market, by End-Use

7.1. Market Snapshot

7.2. Global Prenatal and New-born Genetic Testing Market by End-Use, Performance - Potential Analysis

7.3. Global Prenatal and New-born Genetic Testing Market Estimates & Forecasts by End-Use 2016-2026 (USD Billion)

7.4. Prenatal and New-born Genetic Testing Market, Sub Segment Analysis

7.4.1. Hospitals

7.4.2. Maternity and Speciality Clinics

7.4.3. Diagnostic centres

Chapter 8. Global Prenatal and New-born Genetic Testing Market, Regional Analysis

8.1. Prenatal and New-born Genetic Testing Market, Regional Market Snapshot

8.2. North America Prenatal and New-born Genetic Testing Market

8.2.1. U.S. Prenatal and New-born Genetic Testing Market

8.2.1.1. Technology breakdown estimates & forecasts, 2016-2026

8.2.1.2. Disease breakdown estimates & forecasts, 2016-2026

8.2.1.3. End-Use breakdown estimates & forecasts, 2016-2026

8.2.2. Canada Prenatal and New-born Genetic Testing Market

8.3. Europe Prenatal and New-born Genetic Testing Market Snapshot

8.3.1. U.K. Prenatal and New-born Genetic Testing Market

8.3.2. Germany Prenatal and New-born Genetic Testing Market

8.3.3. Rest of Europe Prenatal and New-born Genetic Testing Market

8.4. Asia-Pacific Prenatal and New-born Genetic Testing Market Snapshot

8.4.1. China Prenatal and New-born Genetic Testing Market

8.4.2. India Prenatal and New-born Genetic Testing Market

8.4.3. Japan Prenatal and New-born Genetic Testing Market

8.4.4. Rest of Asia Pacific Prenatal and New-born Genetic Testing Market

8.5. Latin America Prenatal and New-born Genetic Testing Market Snapshot

8.5.1. Brazil Prenatal and New-born Genetic Testing Market

8.5.2. Mexico Prenatal and New-born Genetic Testing Market

8.6. Rest of The World Prenatal and New-born Genetic Testing Market

Chapter 9. Competitive Intelligence

9.1. Top Market Strategies

9.2. Company Profiles

9.2.1. Abbott Laboratories

9.2.1.1. Key Information

9.2.1.2. Overview

9.2.1.3. Financial (Subject to Data Availability)

9.2.1.4. Disease Summary

9.2.1.5. Recent Developments

9.2.2. Agilent

9.2.3. AutoGenomics

9.2.4. Ariosa Diagnostics

9.2.5. Baebies

9.2.6. Berry Genomics Co. Ltd

9.2.7. BGI

9.2.8. Biocartis Group NV

9.2.9. Natera Inc.

9.2.10. Sequenom Inc.

Chapter 10. Research Process

10.1. Research Process

10.1.1. Data Mining

10.1.2. Analysis

10.1.3. Market Estimation

10.1.4. Validation

10.1.5. Publishing

10.2. Research Attributes

10.3. Research Assumption

List of Tables

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL PRENATAL AND NEW-BORN GENETIC TESTING MARKET

TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL PRENATAL AND NEW-BORN GENETIC TESTING MARKET

TABLE 3. GLOBAL PRENATAL AND NEW-BORN GENETIC TESTING MARKET, REPORT SCOPE

TABLE 4. YEARS CONSIDERED FOR THE STUDY

TABLE 5. EXCHANGE RATES CONSIDERED

TABLE 6. GLOBAL PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)

TABLE 7. GLOBAL PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS BY TECHNOLOGY 2016-2026 (USD BILLION)

TABLE 8. GLOBAL PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS BY DISEASE 2016-2026 (USD BILLION)

TABLE 9. GLOBAL PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS BY END-USE 2016-2026 (USD BILLION)

TABLE 10. GLOBAL PRENATAL AND NEW-BORN GENETIC TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 11. GLOBAL PRENATAL AND NEW-BORN GENETIC TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 12. GLOBAL PRENATAL AND NEW-BORN GENETIC TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 13. GLOBAL PRENATAL AND NEW-BORN GENETIC TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 14. GLOBAL PRENATAL AND NEW-BORN GENETIC TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 15. GLOBAL PRENATAL AND NEW-BORN GENETIC TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 16. GLOBAL PRENATAL AND NEW-BORN GENETIC TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 17. GLOBAL PRENATAL AND NEW-BORN GENETIC TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 18. GLOBAL PRENATAL AND NEW-BORN GENETIC TESTING MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 19. GLOBAL PRENATAL AND NEW-BORN GENETIC TESTING MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 20. U.S. PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 21. U.S. PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 22. U.S. PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 23. CANADA PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 24. CANADA PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 25. CANADA PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 26. UK PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 27. UK PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 28. UK PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 29. GERMANY PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 30. GERMANY PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 31. GERMANY PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 32. ROE PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 33. ROE PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 34. ROE PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 35. CHINA PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 36. CHINA PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 37. CHINA PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 38. INDIA PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 39. INDIA PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 40. INDIA PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 41. JAPAN PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 42. JAPAN PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 43. JAPAN PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 44. ROAPAC PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 45. ROAPAC PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 46. ROAPAC PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 47. BRAZIL PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 48. BRAZIL PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 49. BRAZIL PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 50. MEXICO PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 51. MEXICO PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 52. MEXICO PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 53. ROLA PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 54. ROLA PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 55. ROLA PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 56. ROW PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 57. ROW PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 58. ROW PRENATAL AND NEW-BORN GENETIC TESTING MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2020 World Blood Typing, Grouping and Infectious Disease NAT Screening Market in 68 Countries: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and Instrumentation Review

This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...

  • Publish Date: March 2, 2020
  • $0
View Details
Hearing Aids Market in India 2011

Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...

  • Publish Date: March 10, 2011
  • $950
View Details
Cardiac Pacemaker Market in India 2011

The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...

  • Publish Date: July 18, 2011
  • $950
View Details
 
View More
 

Client Testimonials

2025 © Copyright Big Market Research